Wszolek ZK - Search Results

1

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.

Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T, Hargus G, Deleidi M, Lawson T, Bogetofte H, Perez-Torres E, Clark L, Moskowitz C, Mazzulli J, Chen L, Volpicelli-Daley L, Romero N, Jiang H, Uitti RJ, Huang Z, Opala G, Scarffe LA, Dawson VL, Klein C, Feng J, Ross OA, Trojanowski JQ, Lee VM, Marder K, Surmeier DJ, Wszolek ZK, Przedborski S, Krainc D, Dawson TM, Isacson O. Cooper O, et al. Among authors: wszolek zk. Sci Transl Med. 2012 Jul 4;4(141):141ra90. doi: 10.1126/scitranslmed.3003985. Sci Transl Med. 2012. PMID: 22764206 Free PMC article.

2

A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration.

Wszolek ZK, Uitti RJ, Hutton M. Wszolek ZK, et al. Neurology. 2000 May 23;54(10):2028-30. doi: 10.1212/wnl.54.10.2028. Neurology. 2000. PMID: 10822460 No abstract available.

3

Familial Parkinson's disease and related conditions. Clinical genetics.

Wszolek ZK, Uitti RJ, Markopoulou K. Wszolek ZK, et al. Adv Neurol. 2001;86:33-43. Adv Neurol. 2001. PMID: 11553993 Review. No abstract available.

4

Dopamine agonists, sleep disorders, and driving in Parkinson's disease.

Uitti RJ, Wszolek ZK. Uitti RJ, et al. Among authors: wszolek zk. Adv Neurol. 2003;91:343-9. Adv Neurol. 2003. PMID: 12442692 Review. No abstract available.

5

[The current therapies for parkinson's disease. Part I: pharmacological treatment].

Krygowska-Wajs A, Wszolek ZK, Uitti RJ, Słowinski J, Szczudlik A. Krygowska-Wajs A, et al. Among authors: wszolek zk. Neurol Neurochir Pol. 2003 May-Jun;37(3):665-76. Neurol Neurochir Pol. 2003. PMID: 14593760 Review. Polish.

6

[Current therapies for parkinson's disease. Part II: surgical treatment].

Słowiński J, Wharen RE, Uitti RJ, Wszolek ZK, Krygowska-Wajs A, Mrówka R. Słowiński J, et al. Among authors: wszolek zk. Neurol Neurochir Pol. 2003 May-Jun;37(3):677-86. Neurol Neurochir Pol. 2003. PMID: 14593761 Review. Polish.

7

Is the neuropathological 'gold standard' diagnosis dead? Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder.

Uitti RJ, Calne DB, Dickson DW, Wszolek ZK. Uitti RJ, et al. Among authors: wszolek zk. Parkinsonism Relat Disord. 2004 Dec;10(8):461-3. doi: 10.1016/j.parkreldis.2004.10.001. Parkinsonism Relat Disord. 2004. PMID: 15542004

8

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M. Kachergus J, et al. Among authors: wszolek zk. Am J Hum Genet. 2005 Apr;76(4):672-80. doi: 10.1086/429256. Epub 2005 Feb 22. Am J Hum Genet. 2005. PMID: 15726496 Free PMC article.

9

Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort.

Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ. Uitti RJ, et al. Among authors: wszolek zk. Parkinsonism Relat Disord. 2005 May;11(3):139-45. doi: 10.1016/j.parkreldis.2004.10.007. Parkinsonism Relat Disord. 2005. PMID: 15823477

10

Sporadic SCA8 mutation resembling corticobasal degeneration.

Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK. Baba Y, et al. Among authors: wszolek zk. Parkinsonism Relat Disord. 2005 May;11(3):147-50. doi: 10.1016/j.parkreldis.2004.10.008. Parkinsonism Relat Disord. 2005. PMID: 15823478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

717 results

Search Page

Filters